BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21802952)

  • 1. Molecular and clinical study of McArdle's disease in a cohort of 123 European patients. Identification of 20 novel mutations.
    Vieitez I; Teijeira S; Fernandez JM; San Millan B; Miranda S; Ortolano S; Louis S; Laforet P; Navarro C
    Neuromuscul Disord; 2011 Dec; 21(12):817-23. PubMed ID: 21802952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study.
    Martín MA; Rubio JC; Buchbinder J; Fernández-Hojas R; del Hoyo P; Teijeira S; Gámez J; Navarro C; Fernández JM; Cabello A; Campos Y; Cervera C; Culebras JM; Andreu AL; Fletterick R; Arenas J
    Ann Neurol; 2001 Nov; 50(5):574-81. PubMed ID: 11706962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation.
    Aquaron R; Bergé-Lefranc JL; Pellissier JF; Montfort MF; Mayan M; Figarella-Branger D; Coquet M; Serratrice G; Pouget J
    Neuromuscul Disord; 2007 Mar; 17(3):235-41. PubMed ID: 17324573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients.
    Rubio JC; Garcia-Consuegra I; Nogales-Gadea G; Blazquez A; Cabello A; Lucia A; Andreu AL; Arenas J; Martin MA
    Hum Mutat; 2007 Feb; 28(2):203-4. PubMed ID: 17221871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable presentation of the clinical phenotype of McArdle's disease in a kindred harbouring a novel compound genotype in the muscle glycogen phosphorylase gene.
    Paradas C; Fernandez-Cadenas I; Gallardo E; Lligé D; Arenas J; Illa I; Andreu AL
    Neurosci Lett; 2005 Dec; 391(1-2):28-31. PubMed ID: 16154688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [McArdle disease (gycogenosis type V): analysis of clinical, biological and genetic features of five French patients].
    Delmont E; Sacconi S; Berge-Lefranc JL; Aquaron R; Butori C; Desnuelle C
    Rev Neurol (Paris); 2008 Nov; 164(11):912-6. PubMed ID: 18808785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel mutations in the muscle glycogen phosphorylase gene in McArdle's disease.
    Gámez J; Rubio JC; Martín MA; Fernández-Cadenas I; Garcia-Arumi E; Andreu AL; Arenas J
    Muscle Nerve; 2003 Sep; 28(3):380-2. PubMed ID: 12929201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characterization of McArdle's disease in Brazilian patients.
    Gurgel-Giannetti J; Nogales-Gadea G; van der Linden H; Bellard TM; Brasileiro Filho G; Giannetti AV; de Castro Concentino EL; Vainzof M
    Neuromolecular Med; 2013 Sep; 15(3):470-5. PubMed ID: 23653251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of myophosphorylase deficiency in Dutch patients with McArdle's disease.
    Martín MA; Rubio JC; Wevers RA; Van Engelen BG; Steenbergen GC; Van Diggelen OP; De Visser M; De Die-Smulders C; Blázquez A; Andreu AL; Arenas J
    Ann Hum Genet; 2004 Jan; 68(Pt 1):17-22. PubMed ID: 14748827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease.
    Vissing J; Duno M; Schwartz M; Haller RG
    Brain; 2009 Jun; 132(Pt 6):1545-52. PubMed ID: 19433441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Private mutations in the myophosphorylase gene: the first case in a patient of Latin American descent].
    Fernandez-Cadenas I; Nogales-Gadea G; Llige D; Rubio JC; Montaner J; Arenas J; Raspall-Chaure M; Roig-Quilis M; Andreu AL
    Rev Neurol; 2007 Sep 1-15; 45(5):280-3. PubMed ID: 17876739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations.
    Deschauer M; Morgenroth A; Joshi PR; Gläser D; Chinnery PF; Aasly J; Schreiber H; Knape M; Zierz S; Vorgerd M
    J Neurol; 2007 Jun; 254(6):797-802. PubMed ID: 17404776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease.
    Nogales-Gadea G; Pinós T; Lucia A; Arenas J; Camara Y; Brull A; de Luna N; Martín MA; Garcia-Arumí E; Martí R; Andreu AL
    Brain; 2012 Jul; 135(Pt 7):2048-57. PubMed ID: 22730558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new stop codon mutation (Y52X) in the myophosphorylase gene in a Greek patient with McArdle's disease.
    Hadjigeorgiou GM; Papadimitriou A; Musumeci O; Paterakis K; Flabouriari K; Shanske S; DiMauro S
    J Neurol Sci; 2002 Feb; 194(1):83-6. PubMed ID: 11809171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis in myophosphorylase deficiency (McArdle's disease).
    Vorgerd M; Kubisch C; Burwinkel B; Reichmann H; Mortier W; Tettenborn B; Pongratz D; Lindemuth R; Tegenthoff M; Malin JP; Kilimann MW
    Ann Neurol; 1998 Mar; 43(3):326-31. PubMed ID: 9506549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations in patients with McArdle disease by analysis of skeletal muscle mRNA.
    García-Consuegra I; Rubio JC; Nogales-Gadea G; Bautista J; Jiménez S; Cabello A; Lucía A; Andreu AL; Arenas J; Martin MA
    J Med Genet; 2009 Mar; 46(3):198-202. PubMed ID: 19251976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two new mutations in the myophosphorylase gene in Italian patients with McArdle's disease.
    Bruno C; Lanzillo R; Biedi C; Iadicicco L; Minetti C; Santoro L
    Neuromuscul Disord; 2002 Jun; 12(5):498-500. PubMed ID: 12031624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [McArdle's disease in adults: clinical and genetic study].
    Olmos JM; Zarrabeitia MT; Valero MC; Figols J; Matorras P; Riancho JA
    Med Clin (Barc); 1997 Nov; 109(19):753-5. PubMed ID: 9470186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay.
    Nogales-Gadea G; Rubio JC; Fernandez-Cadenas I; Garcia-Consuegra I; Lucia A; Cabello A; Garcia-Arumi E; Arenas J; Andreu AL; Martín MA
    Hum Mutat; 2008 Feb; 29(2):277-83. PubMed ID: 17994553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Late diagnosis of a McArdle disease's case (type V glycogenosis)].
    Flavier S; Rolland MO; Eude M; Fédou C; Brun JF; Maire I; Mercier J; Raynaud E
    Ann Biol Clin (Paris); 2007; 65(5):550-4. PubMed ID: 17913675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.